Amyloid Beta Precursor Protein Binding Protein A3 (APBA3) Antibody

286€ (100 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Amyloid Beta Precursor Protein Binding Protein A3 (APBA3) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx129372
tested applications
WB, IHC, IF/ICC
Description
APBA3 Antibody is a Rabbit Polyclonal against APBA3.
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Primary Antibodies |
Immunogen Target | Amyloid Beta Precursor Protein Binding Protein A3 (APBA3) |
Host | Rabbit |
Reactivity | Mouse |
Recommended Dilution | WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Polyclonal |
Conjugation | Unconjugated |
Purification | Purified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography. |
Size 1 | 100 µl |
Size 2 | 200 µl |
Size 3 | 1 ml |
Form | Liquid |
Tested Applications | WB, IHC, IF/ICC |
Buffer | 0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol. |
Availability | Shipped within 5-7 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
Alias | APBA3, MGC:15815, X11L2, mint3, amyloid beta precursor protein binding family A member 3 |
Background | Antibody anti-APBA3 |
Status | RUO |
Descripción
APBA3, another member of the X11 protein family, is involved in the binding and regulation of the amyloid-beta precursor protein (APP). Unlike other members, APBA3 is highly expressed in a variety of tissues, including brain, heart, and liver, where it regulates both APP trafficking and protein stability. It binds APP through its phosphotyrosine-binding (PTB) domain and modulates its intracellular transport, preventing abnormal amyloid-beta production. APBA3 has additional roles beyond APP regulation, including its participation in vesicular transport, endocytosis, and regulation of apoptotic pathways. The protein is also implicated in immune regulation, where it interacts with components of the Toll-like receptor signaling pathway, suggesting a role in inflammatory responses. Dysregulation of APBA3 expression can contribute to amyloid plaque formation, mitochondrial dysfunction, and oxidative stress, particularly in neurodegenerative disorders such as Alzheimer’s disease. Furthermore, its involvement in cellular apoptosis suggests that APBA3 may also play a role in cancer progression and metabolic disorders. Understanding its mechanisms in APP metabolism and cellular signaling offers promising therapeutic opportunities to target neurodegenerative conditions and inflammatory processes.
Related Products

Amyloid-Beta A4 Precursor Protein-Binding Family A Member 1 (APBA1) Antibody
Rabbit Polyclonal against the APBA1 protein.
Ver Producto
Human Amyloid-beta Precursor Protein (APP) CLIA Kit
Human Beta-Amyloid Precursor Protein (APP) Chemiluminescent Immunoassay (CLIA) Kit is a Chemiluminescent Immunoassay (CLIA) kit against Beta-Amyloid Precursor Protein (APP).
Ver Producto
beta Amyloid / A4 Protein Precursor (APP), analog
β-Amyloid/A4 Protein Precursor (APP) (96-110), analog is a peptide.
Ver Producto